SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-22-008420
Filing Date
2022-05-12
Accepted
2022-05-12 07:07:36
Documents
14
Period of Report
2022-05-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K alt-20220512x8k.htm   iXBRL 8-K 45369
2 EX-99.1 alt-20220512xex99d1.htm EX-99.1 146543
3 GRAPHIC alt-20220512xex99d1002.jpg GRAPHIC 7092
  Complete submission text file 0001558370-22-008420.txt   336550

Data Files

Seq Description Document Type Size
4 EX-101.SCH alt-20220512.xsd EX-101.SCH 3051
5 EX-101.LAB alt-20220512_lab.xml EX-101.LAB 15908
6 EX-101.PRE alt-20220512_pre.xml EX-101.PRE 10121
8 EXTRACTED XBRL INSTANCE DOCUMENT alt-20220512x8k_htm.xml XML 4868
Mailing Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878
Business Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878 2406541450
Altimmune, Inc. (Filer) CIK: 0001326190 (see all company filings)

IRS No.: 202726770 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32587 | Film No.: 22915668
SIC: 2834 Pharmaceutical Preparations